Systemic administration of ladiratuzumab vedotin alone or in combination with pembrolizumab results in significant immune activation in the tumor microenvironment in metastatic breast cancer patients Meeting Abstract
| Authors: | Pusztai, L.; Lu, H.; Hale, C.; Grosse-Wilde, A.; Specht, J.; Modi, S.; Han, H.; Cortes, J.; Oliveira, M.; Garfin, P.; Wang, Z.; Onsum, M. |
| Abstract Title: | Systemic administration of ladiratuzumab vedotin alone or in combination with pembrolizumab results in significant immune activation in the tumor microenvironment in metastatic breast cancer patients |
| Meeting Title: | 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 8 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Nov 9-14 |
| Meeting Location: | Virtual |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2020-11-01 |
| Start Page: | A198 |
| End Page: | A199 |
| Language: | English |
| ACCESSION: | WOS:000616665300314 |
| DOI: | 10.1136/jitc-2020-SITC2020.0323 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 323 -- Source: Wos |
